Form D · Other
Scarless Laboratories, Inc.
Beverly Hills, CA · CIK 0001514710
Offering snapshot reported Apr 13, 2011 · SEC filing
- Reported sold
- $150K Offering amount: $150K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 31, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 13, 2011 | Initial | $150,000 | No comparison | 1 | SEC filing |
| Apr 13, 2011 | Initial | $400,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-158286
Series A-1 Preferred Stock and the underlying shares of Common Stock issuable upon conversion of Series A-1 Preferred Stock.
Source: Form D, filed Apr 13, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carol Danielson | Executive |
| Shuai Hung Lin | Director |
| Chia Soo | Director, Executive |
| Kang Ting | Director |
Issuer details
Industry: Other (See others in industry)
Address:
369 South Doheny Drive, Suite 1201
Beverly Hills, CA, 90211
Beverly Hills, CA, 90211